Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
The McGill Pain Questionnaire: Major properties and scoring methods
1975 • 6,706 citations
The development of a method for assessing the quality of life of cancer patients
1984 • 274 citations
STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO
1974 • 192 citations
Is there evidence that chemotherapy is of benefit to patients with carcinoma of the prostate?
1985 • 172 citations
Orchiectomy for advanced prostatic carcinoma A reevaluation
1973 • 127 citations
Treatment of Stage IV Carcinoma of the Prostate
1975 • 123 citations
A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II
1979 • 103 citations
SEX HORMONE BINDING GLOBULIN BINDING CAPACITY, TESTOSTERONE, 5α-DIHYDROTESTOSTERONE, OESTRADIOL AND PROLACTIN IN PLASMA OF PATIENTS WITH PROSTATIC CARCINOMA UNDER VARIOUS TYPES OF HORMONAL TREATMENT
1977 • 98 citations
Current Status of Bilateral Adrenalectomy or Advanced Prostatic Carcinoma
1974 • 90 citations
Sch 13521 In The Treatment Of Advanced Carcinoma Of The Prostate
1974 • 90 citations
The Brompton mixture versus morphine solution given orally: effects on pain.
1979 • 65 citations
Cortisone Treatment in Advanced Carcinoma of the Prostate
1954 • 62 citations
Androgen Suppression by Hydrocortisone without Aminoglutethimide in Orchiectomised Men with Prostatic Cancer
1987 • 58 citations
Treatment of advanced prostatic cancer, resistant to conventional therapy with aminoglutethimide
1985 • 42 citations
The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients
1988 • 36 citations
Adrenal androgen blockade in relapsed prostate cancer
1985 • 27 citations
Cited By (0)
No citing papers found in database